勒梅特微管醫療 LMAT 深滬

已收盤 02-06 16:00:00 美东时间

87.42

+0.430

+0.49%

華盛通

立即下載

最高88.725
今開87.16
成交量 13.00万股
最低 86.81
昨收 86.99
總市值 19.83亿
52周最高 104.75
市盈率 ^靜 45.22
換手率 0.57%
52周最低 70.82
委比 49.63%
總股本 2268.60万
歷史最高 108.78
量比 0.97
振幅 2.20%
歷史最低 0.195
每手 1
風險率 5.48%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

LeMaitre to Participate in Upcoming Investor Conferences

LeMaitre Vascular, Inc. announced that management will participate in three upcoming investor conferences. Dorian LeBlanc, CFO, will present at the Jefferies London Healthcare Conference 2025 on November 18, 2025, at Waldorf Hilton, London, at 8:00 AM GMT. David Roberts, President, will present at the Wolfe Research 7th Annual Healthcare Conference on November 19, 2025, at Wolfe NYC Offices, New York, NY, at 10:40 AM ET. Dorian LeBlanc will also ...

2025-11-12 21:13
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 10:22
LeMaitre Vascular declares $0.20 dividend

LeMaitre Vascular (LMAT) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.93% Payable Dec. 4; for shareholders of record Nov. 20; ex-div Nov. 20. See LMAT Dividend Score...

2025-11-07 13:33
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调

今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元

2025-11-06 09:55
Roth Capital Reinstates Buy on LeMaitre Vascular, Announces $108 Price Target

Roth Capital analyst Kyle Bauser reinstates LeMaitre Vascular (NASDAQ:LMAT) with a Buy and announces $108 price target.

2025-11-06 01:29
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元

今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元

2025-09-24 10:23
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 price target.

2025-09-23 23:15

派息除權日	每股總股息	派息日期
2025-11-20	0.20	2025-12-04
2025-08-21	0.20	2025-09-04
2025-05-15	0.20	2025-05-29
2025-03-13	0.20	2025-03-27
2024-11-21	0.16	2024-12-05
2024-08-15	0.16	2024-08-29
2024-05-15	0.16	2024-05-30
2024-03-13	0.16	2024-03-28
2023-11-15	0.14	2023-11-30
2023-08-16	0.14	2023-08-31
2023-05-16	0.14	2023-06-01
2023-03-08	0.14	2023-03-23
2022-11-16	0.13	2022-12-01
2022-08-24	0.13	2022-09-08
2022-05-16	0.13	2022-06-02
2022-03-07	0.13	2022-03-24
2021-11-18	0.11	2021-12-02
2021-08-25	0.11	2021-09-09
2021-05-18	0.11	2021-06-03
2021-03-08	0.11	2021-03-25
2020-11-18	0.09	2020-12-03
2020-08-26	0.09	2020-09-10
2020-05-19	0.09	2020-06-04
2020-03-02	0.09	2020-03-19
2019-11-19	0.09	2019-12-05
2019-08-20	0.09	2019-09-05
2019-05-21	0.09	2019-06-06
2019-03-21	0.09	2019-04-05
2018-11-19	0.07	2018-12-06
2018-08-21	0.07	2018-09-06
2018-05-21	0.07	2018-06-07
2018-03-21	0.07	2018-04-05
2017-11-21	0.05	2017-12-07
2017-08-21	0.05	2017-09-07
2017-05-22	0.05	2017-06-08
2017-03-20	0.05	2017-04-06
2016-11-17	0.05	2016-12-05
2016-08-18	0.05	2016-09-06
2016-05-23	0.05	2016-06-08
2016-03-17	0.05	2016-04-04
2015-11-18	0.04	2015-12-04
2015-08-18	0.04	2015-09-03
2015-05-20	0.04	2015-06-05
2015-03-18	0.04	2015-04-03
2014-11-18	0.04	2014-12-04
2014-08-19	0.04	2014-09-04
2014-05-20	0.04	2014-06-05
2014-03-18	0.04	2014-04-03
2013-11-18	0.03	2013-12-04
2013-08-19	0.03	2013-09-04
2013-05-20	0.03	2013-06-05
2013-03-18	0.03	2013-04-03
2012-11-16	0.03	2012-12-04
2012-08-15	0.03	2012-09-04
2012-05-16	0.03	2012-06-04
2012-03-16	0.03	2012-04-03
2011-11-21	0.02	2011-12-06
2011-08-17	0.02	2011-09-06
2011-05-18	0.02	2011-06-06
2011-03-18	0.02	2011-04-05

公司名稱	勒梅特微管医疗
行業分類	医疗设备
業務描述	LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

勒梅特微管醫療 LMAT 深 滬

87.42

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

勒梅特微管醫療 LMAT 深滬